comparemela.com

Latest Breaking News On - Bleeding academic research consortium - Page 13 : comparemela.com

Association of Dual Antiplatelet Therapy With Ticagrelor With Vein Graft Failure After Coronary Artery Bypass Graft Surgery: A Systematic Review and Meta-analysis | Cardiology | JAMA

This systematic review and individual patient data meta-analysis of randomized clinical trials compares the effects of ticagrelor dual antiplatelet therapy or t

Cochrane libraryAcademic research consortiumBleeding academic research consortium

Long-term clopidogrel confers less MACCE, bleeding events vs aspirin after PCI

ATLANTA — Clopidogrel monotherapy after 12 months of event free post-PCI dual antiplatelet therapy was associated with fewer MACCE and bleeding events vs. aspirin monotherapy in high bleeding risk patients, a speaker reported.Data presented at the Society for Cardiovascular Angiography and Interventions Scientific Sessions, showed that, at 30 months post-PCI, patients taking the P2Y12

Hao yu wangScott buzbyUnion medical collegeNational centerAcademic research consortiumClinical researchKey laboratory of cardiovascular diseaseChinese academy of medical sciencesSociety for cardiovascular angiographyCardiovascular angiographyInterventions scientific sessionsChinese academyMedical sciencesPeking union medicalBleeding academic research consortiumFuwai hospital

FAME 3 Subanalysis Adds Twist to Negative Primary Results

A quality-of-life subanalysis suggests PCI with fractional flow reserve might be preferred over CABG by at least some patients.

United statesFrederikm zimmermanWilliamf fearonStanford calif universityAcademic research consortiumAmerican college of cardiologyBoston scientificAmerican collegeCatharina hospitalCardiovascular therapeuticsNew england journalEuropean qualityCanadian cardiovascular classificationBleeding academic research consortiumAbbott vascularAngina pectoris

Ticagrelor after 3-month DAPT post-PCI may benefit patients with high bleeding risk

Ticagrelor after 3-month DAPT post-PCI may benefit patients with high bleeding risk
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Javier escanedAcademic research consortiumEuropean heart journalBleeding academic research consortiumHospital clinico san carlos

Experts Debate Aspirin for Primary Prevention in Type 2 Diabetes

At IDF 2021, two speakers presented different views on the benefit-risk balance of cardiovascular protection versus bleeding risk in those who haven t already had a vascular event.

United statesUnited kingdomJane armitageBianca roccaEuropean association for the study of diabetesAcademic research consortiumUniversity of oxfordAmerican diabetes associationUs preventive services task forceEuropean society of cardiologyCatholic university school of medicineInternational diabetes federationEuropean societyEuropean associationServices task forceMedscape medical

vimarsana © 2020. All Rights Reserved.